title: Insulin-like growth factor-II in nonislet cell tumors associated with hypoglycemia: increased levels of messenger ribonucleic acid.
abstract: The role of insulin-like growth factor-II (IGF-II) in the hypoglycemia associated with nonislet cell tumors is controversial. In this study we have addressed this question by measuring the IGF-II mRNA levels in extracts of these tumors. Hybridization of a 32P-labeled IGF-II cDNA to a Northern blot of RNA from three nonislet cell tumors associated with hypoglycemia (a hemangiopericytoma, fibrosarcoma, and malignant mesenchymal tumor) demonstrated six hybridizing bands, 6.8, 5.6, 4.7, 3.6, 2.6, and 2.1 kilobases in length. These bands were similar to those described by others in a range of tumors and normal tissues. Tissue IGF-II mRNA levels were quantitated using a solution hybridization/RNase protection assay. IGF-II mRNA levels in the tumors were similar to the level present in one line of human hepatoblastoma-derived Hep G2 cells, 5- to 6-fold higher than that in another line of Hep G2 cells, and 2- to 3-fold higher than that in term placenta. In contrast, little or no IGF-II mRNA was detected in a nonfunctioning islet cell adenoma or normal spleen. There was no evidence for amplification of the IGF-II gene in the one tumor in which it was sought. These data suggest that nonislet cell tumors associated with hypoglycemia produce large amounts of IGF-II mRNA and that this IGF-II mRNA appears to be the product of an IGF-II gene, which is apparently normal in the region encoding mature IGF-II peptide.
authors.affiliation: Diabetes Branch, National Institute of Diabetes, and Digestive and Kidney Diseases, Bethesda, Maryland 20892.
authors.forename: W L
authors.initials: WL
authors.lastname: Lowe
authors.forename: C T
authors.initials: CT
authors.lastname: Roberts
authors.forename: D
authors.initials: D
authors.lastname: LeRoith
authors.forename: M T
authors.initials: MT
authors.lastname: Rojeski
authors.forename: T J
authors.initials: TJ
authors.lastname: Merimee
authors.forename: S T
authors.initials: ST
authors.lastname: Fui
authors.forename: H
authors.initials: H
authors.lastname: Keen
authors.forename: D
authors.initials: D
authors.lastname: Arnold
authors.forename: J
authors.initials: J
authors.lastname: Mersey
authors.forename: S
authors.initials: S
authors.lastname: Gluzman
mesh_terms: D000328:Adult; D000368:Aged; D015152:Blotting, Northern; D015139:Blotting, Southern; D002478:Cells, Cultured; D004273:DNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology*; D007335:Insulin-Like Growth Factor II / Q000235:genetics*; D008214:Lymphocytes / Q000378:metabolism; D008297:Male; D009693:Nucleic Acid Hybridization; D010190:Pancreatic Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000601:surgery; D012333:RNA, Messenger / Q000032:analysis* / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D013002:Somatomedins / Q000235:genetics*; D014158:Transcription, Genetic
chemical_list: D004273:DNA, Neoplasm; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D013002:Somatomedins; D007335:Insulin-Like Growth Factor II